Previous 10 | Next 10 |
home / stock / bmxmf / bmxmf news
bioMérieux S.A. (BMXMF) Q4 2021 Earnings Conference Call March 02, 2022, 08:30 AM ET Company Participants Franck Admant - IR Alexandre Mérieux - Chairman and CEO Guillaume Bouhours - CFO Conference Call Participants Maja Pataki - Kepler Presentation Operator Good day, and welcome to...
bioMérieux S.A. (OTCPK:BMXMF): FY GAAP EPS of €5.06. Revenue of €3.37M (+8.4% Y/Y).€ For further details see: bioMérieux S.A. GAAP EPS of €5.06, revenue of €3.37M
bioMérieux S.A. (BMXMF) Q3 2021 Earnings Conference Call October 21, 2021 09:00 AM ET Company Participants Franck Admant - Investor Relations Alexandre Mérieux - Chairman & Chief Executive Officer Guillaume Bouhours - Chief Financial Officer Conference Call Participants Hugo Sol...
bioMérieux is a leading developer and producer of in vitro diagnostic solutions with a focus on infectious diseases. The Company has a solid financial structure to support growth. Increased recognition of the value of diagnostics and molecular solutions gives the company an a...
Beacon Roofing Supply, Inc. (BMXMF) Q4 2020 Earnings Conference Call February 24, 2021, 09:00 AM ET Company Participants Franck Admant - Director of IR Alexandre Mérieux - Chairman & CEO Guillaume Bouhours - Executive VP of Purchasing and Information Systems & CFO Conference Call...
bioMérieux SA (BMXMF) Q2 2020 Results Conference Call September 2, 2020 8:30 AM ET Company Participants Sylvain Morgeau - IR Alexandre Mérieux - Chairman and CEO Guillaume Bouhours - CFO Conference Call Participants Catherine Tennyson - Bank of America Hugo Solv...
The following slide deck was published by bioMérieux S.A. in conjunction with their 2020 Q2 earnings Read more ...
Help is on the way. In the midst of a societal upheaval resulting from the novel coronavirus and the disease that it causes, COVID-19, there are many efforts in progress to find solutions to slow the spread of the disease and treat those who already have it. These efforts include those from gov...
bioMérieux S.A. (BMXMF) Q4 2019 Earnings Conference Call February 26, 2020 8:30 AM ET Company Participants Sylvain Morgeau - Manager, Investor Relations Alexandre Mérieux - Chief Executive Officer Guillaume Bouhours - Chief Financial Officer Conference Call Participa...
Biomerieux SA (BMXMF) Q2 2018 Results Conference Call September 05, 2018 08:30 AM Executives Sylvain Morgeau - Investor Relations Alexandre Mérieux - Chief Executive Officer Guillaume Bouhours - Chief Financial Officer Analysts RomainZana - Exane Bill Quirk - Piper J...
News, Short Squeeze, Breakout and More Instantly...
Biomerieux SA Company Name:
BMXMF Stock Symbol:
OTCMKTS Market:
Biomerieux (BMXMF) is expected to report for Q1 2024 Conn's Inc. (CONN) is expected to report $-0.65 for Q1 2025 Cognetivity Neurosciences Ltd (CGNSF) is expected to report for quarter end 2024-04-30 Aridis Pharmaceuticals Inc. (ARDS) is expected to report for Q1 2024 China Jo-Jo ...
DS Smith Plc. (DITHF) is expected to report for Q4 2024 Bluegreen Vacations Holding Corporation - Class B (BVHBB) is expected to report for Q1 2024 Harbour Energy Plc ADR (HBRIY) is expected to report for Q1 2024 Bayerische Motoren Werke AG (BAMXF) is expected to report for Q1 2024 ...
Commercial Metals Company (CMC) is expected to report $1 for Q3 2024 CREATD INC. (CRTD) is expected to report for Q1 2024 GMS Inc. (GMS) is expected to report $2.04 for Q4 2024 China Jo-Jo Drugstores Inc. (CJJD) is expected to report for Q4 2024 Eiger BioPharmaceuticals Inc. (EIGR...